Current assets: Cash and marketable securities Accounts receivable Inventory Total Assets Fixed assets: Gross plant and equipment. Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets 2024 Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses. VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) $ 72 187 312 $ 571 $ 1,073 146 $ 927 134 2023 $ 71 181 291 $ 543 $ 882 113 $ 769 134 $ 903 $ 1,061 $ 1,632 $1,446 Liabilities and Equity Current liabilities: Accrued wages and taxes Accounts payable Notes payable Total Long-term debt Stockholders' equity: Preferred stock (6 thousand shares) Common stock and paid-in surplus (100 thousand shares) Retained earnings Total Total liabilities and equity VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained earnings Per (common) share data: Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) 2024 $ 892 389 $ 503 47 $ 456 33 $ 423 48 $ 375 79 $ 296 $6 $ 290 130 $ 160 $ 2.90 $ 1.30 $ 7.31 $ 8.34 2023 $ 802 352 $ 450 41 $ 409 31 $ 378 42 $ 336 71 $ 265 $6 $ 259 130 $ 129 $ 2.59 $ 1.30 $ 5.71 $ 6.19 2024 $ 46 147 131 $ 324 $ 571 $6 120 611 $737 $ 1,632 2023 $ 41 141 131 $ 313 $ 556 $6 120 451 $ 577 $ 1,446

FINANCIAL ACCOUNTING
10th Edition
ISBN:9781259964947
Author:Libby
Publisher:Libby
Chapter1: Financial Statements And Business Decisions
Section: Chapter Questions
Problem 1Q
icon
Related questions
icon
Concept explainers
Topic Video
Question
Current assets:
Cash and marketable securities
Accounts receivable
Inventory
Total
Assets
Fixed assets:
Gross plant and equipment
Less: Accumulated depreciation
Net plant and equipment
Other long-term assets
Total
Total assets
Net sales
Less: Cost of goods sold
Gross profits
Less: Other operating expenses
2024
VALIUM'S MEDICAL SUPPLY CORPORATION
Balance Sheet as of December 31, 2024 and 2023
(in millions of dollars)
$ 72
187
312
$ 571
Earnings per share (EPS)
Dividends per share (DPS)
Book value per share (BVPS)
Market value (price) per share (MVPS)
2023
$ 71
181
291
$ 543
$ 1,073
146
$ 927
134
$ 1,061
$ 1,632 $ 1,446
$ 882
113
$ 769
134
$ 903
Liabilities and Equity
Current liabilities:
Accrued wages and taxes
Accounts payable
Notes payable
Total
Long-term debt
Stockholders' equity:
Preferred stock (6 thousand shares)
Common stock and paid-in surplus (100 thousand shares)
Retained earnings
Total
VALIUM'S MEDICAL SUPPLY CORPORATION
Income Statement for Years Ending December 31, 2024 and 2023
(in millions of dollars)
Total liabilities and equity
Earnings before interest, taxes, depreciation, and amortization (EBITDA)
Less: Accumulated depreciation
Earnings before interest and taxes (EBIT)
Less: Interest
Earnings before taxes (EBT)
Less: Taxes
Net income
Less: Preferred stock dividends
Net income available to common stockholders
Less: Common stock dividends
Addition to retained arning
Per (common) share data:
2024
$ 892
389
$ 503
47
$ 456
33
$ 423
48
$ 375
79
$ 296
$ 6
$ 290
130
$ 160
$ 2.90
$ 1.30
$ 7.31
$ 8.34
2023
$ 802
352
$ 450
41
$ 409
31
$ 378
42
$ 336
71
$ 265
$ 6
$ 259
130
$ 129
$ 2.59
$ 1.30
$ 5.71
$ 6.19
2024
$ 46
147
131
$ 324
$ 571
$ 6
120
611
$ 737
$ 1,632
2023
$ 41
141
131
$ 313
$ 556
$ 6
120
451
$ 577
$ 1,446
Transcribed Image Text:Current assets: Cash and marketable securities Accounts receivable Inventory Total Assets Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses 2024 VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) $ 72 187 312 $ 571 Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) 2023 $ 71 181 291 $ 543 $ 1,073 146 $ 927 134 $ 1,061 $ 1,632 $ 1,446 $ 882 113 $ 769 134 $ 903 Liabilities and Equity Current liabilities: Accrued wages and taxes Accounts payable Notes payable Total Long-term debt Stockholders' equity: Preferred stock (6 thousand shares) Common stock and paid-in surplus (100 thousand shares) Retained earnings Total VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and 2023 (in millions of dollars) Total liabilities and equity Earnings before interest, taxes, depreciation, and amortization (EBITDA) Less: Accumulated depreciation Earnings before interest and taxes (EBIT) Less: Interest Earnings before taxes (EBT) Less: Taxes Net income Less: Preferred stock dividends Net income available to common stockholders Less: Common stock dividends Addition to retained arning Per (common) share data: 2024 $ 892 389 $ 503 47 $ 456 33 $ 423 48 $ 375 79 $ 296 $ 6 $ 290 130 $ 160 $ 2.90 $ 1.30 $ 7.31 $ 8.34 2023 $ 802 352 $ 450 41 $ 409 31 $ 378 42 $ 336 71 $ 265 $ 6 $ 259 130 $ 129 $ 2.59 $ 1.30 $ 5.71 $ 6.19 2024 $ 46 147 131 $ 324 $ 571 $ 6 120 611 $ 737 $ 1,632 2023 $ 41 141 131 $ 313 $ 556 $ 6 120 451 $ 577 $ 1,446
Note: Enter your answers in millions of dollars. Amounts to be deducted should be in
Statement of Cash Flows for Year Ending December 31, 2024
(in millions of dollars)
Cash flows from operating activities
Additions (sources of cash):
Subtractions (uses of cash):
Net cash flow from operating activities
Cash flows from investing activities
Subtractions:
Net cash flow from investing activities
Cash flows from financing activities
Additions:
Subtractions:
Net cash flow from financing activities
Net change in cash and marketable securities
Transcribed Image Text:Note: Enter your answers in millions of dollars. Amounts to be deducted should be in Statement of Cash Flows for Year Ending December 31, 2024 (in millions of dollars) Cash flows from operating activities Additions (sources of cash): Subtractions (uses of cash): Net cash flow from operating activities Cash flows from investing activities Subtractions: Net cash flow from investing activities Cash flows from financing activities Additions: Subtractions: Net cash flow from financing activities Net change in cash and marketable securities
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Knowledge Booster
Financial Statements
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, accounting and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
FINANCIAL ACCOUNTING
FINANCIAL ACCOUNTING
Accounting
ISBN:
9781259964947
Author:
Libby
Publisher:
MCG
Accounting
Accounting
Accounting
ISBN:
9781337272094
Author:
WARREN, Carl S., Reeve, James M., Duchac, Jonathan E.
Publisher:
Cengage Learning,
Accounting Information Systems
Accounting Information Systems
Accounting
ISBN:
9781337619202
Author:
Hall, James A.
Publisher:
Cengage Learning,
Horngren's Cost Accounting: A Managerial Emphasis…
Horngren's Cost Accounting: A Managerial Emphasis…
Accounting
ISBN:
9780134475585
Author:
Srikant M. Datar, Madhav V. Rajan
Publisher:
PEARSON
Intermediate Accounting
Intermediate Accounting
Accounting
ISBN:
9781259722660
Author:
J. David Spiceland, Mark W. Nelson, Wayne M Thomas
Publisher:
McGraw-Hill Education
Financial and Managerial Accounting
Financial and Managerial Accounting
Accounting
ISBN:
9781259726705
Author:
John J Wild, Ken W. Shaw, Barbara Chiappetta Fundamental Accounting Principles
Publisher:
McGraw-Hill Education